Sanofi
Sanofi’s Sarclisa combo approved in Europe for relapsed/refractory multiple myeloma
June 2, 2020Manufacturing and Production, Sales and Marketing Europe, Sanofi, Sarclisa, pharma
Sanofi has scored a new approval from the European Commission for the use of its CD38 inhibitor Sarclisa (isatuximab) in …
FDA approves Sanofi’s Dupixent for children with dermatitis
May 27, 2020Research and Development Dupixent, Sanofi, atopic eczema
The FDA has approved Sanofi’s Dupixent (dupilumab) for children between ages 6 to 11 with moderate to severe atopic dermatitis. …
French based Sanofi will ship COVID-19 vaccine to the US first
May 14, 2020Business Services COVID-19, Sanofi, Vaccine
French based pharmaceutical company Sanofi has announced it will ship its COVID-19 vaccine that is in development to the US …
Sanofi and Regeneron’s Libtayo shows durable responses in world’s most common skin cancer
May 5, 2020Manufacturing and Production, Research and Development Cancer, Libtayo, Regeneron, Sanofi
Sanofi and Regeneron’s have lifted the lid on new topline data on their PD-1 inhibitor Libtayo (cemiplimab) in patients with …
Phase 3 Libtayo monotherapy trial halted early due to strong benefit in advanced non-small cell lung cancer
April 29, 2020Research and Development Cancer, Libtayo, Regeneron, Sanofi, lung cancer
A Phase 3 study of Sanofi and Regeneron’s Libtayo (cemiplimab) as a monotherapy for advanced or metastatic non-small cell lung …
Sanofi’s Meningococcal Conjugate Vaccine secures FDA approval in patients aged two and up
April 27, 2020Sales and Marketing FDA, MenQuadfi, Sanofi, US, meningococcal disease, pharma
Sanofi’s MedQuadfi Meningococcal Conjugate Vaccine has scored FDA approval for the prevention of invasive meningococcal disease, becoming the first and …
Scottish Medicines Consortium approves new drugs in multiple sclerosis, ulcerative colitis and diabetes
April 15, 2020Research and Development, Sales and Marketing Biogen, Fambyra, Janssen, NHS, Rimzoic, Sandoz, Sanofi, Scotland, Scottish Medicines Consortium, Stelara, Suliqua, pharma
Medical regulation must still continue even in a global pandemic, and the Scottish Medicines Consortium, (SMC) has ploughed on with …
Sanofi and GSK set aside rivalry with “unprecedented” COVID-19 vaccine partnership
April 15, 2020Research and Development COVID-19, GSK, Sanofi, coronavirus
Usual rivals Sanofi and GlaxoSmithKline have said they are to put aside competition with the forging of a new “unprecedented …
Sanofi and Regeneron’s Dupixent combo impresses in paediatric atopic dermatitis
April 3, 2020Medical Communications, Research and Development Dupixent, Sanofi, atopic dermatitis, pharma
Sanofi and Regeneron have unveiled new Phase 3 data for their IL-4 and IL-13 inhibitor Dupixent (dupilumab), showing strong results …
FDA calls for heartburn drug Zantac to be pulled due to carcinogen concerns
April 2, 2020Business Services FDA, NDMA, Sanofi, heartburn
The FDA is requesting that manufactures remove Zantac (ranitidine) from the market due to risks of it containing a carcinogen. …
NICE shoots down Dupixent for severe asthma
March 9, 2020Sales and Marketing Dupixent, NHS, NICE, Regeneron, Sanofi, UK, asthma
NICE, the NHS’ drug watchdog in England and Wales, has announced its decision not to recommend Sanofi and Regeneron’s IL-4 …
Sanofi scores FDA approval for Sarclisa combo in relapsed, refractory multiple myeloma
March 3, 2020Manufacturing and Production, Sales and Marketing Cancer, Sanofi, Sarclisa, multiple myeloma, pharma
Sanofi’s monoclonal antibody and CD-38 inhibitor Sarclisa (isatuximab-irfc) has been awarded marketing authorisation from the FDA in the treatment of …
Sanofi set to pay $11.9 million to resolve kickback probe, US Justice Department announces
March 2, 2020Sales and Marketing Co pays, Justice department, Medicaid, Medicare, Sanofi, insurance
The Justice Department have announced that Sanofi SA have agreed to pay $11.85 million to resolve allegations it used a …
World’s second largest API company to be created by Sanofi
February 25, 2020Manufacturing and Production API, APIs, China API, Coronavirus API, India API, Sanofi
Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …
Sanofi axes four major players from its executive committee
February 13, 2020Manufacturing and Production, Medical Communications Sanofi, appointments, pharma
Sanofi has announced it will cull its executive committee under plans orchestrated by new Chief Executive Officer Paul Hudson, who …
